Vivos (RDGL) Interest Coverage Ratio Growth (3y) (2013 - 2025)
Vivos (RDGL) Interest Coverage Ratio Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | -10.66% |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 61.88% |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 46.62% |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | -36.73% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | -2.41% |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 9.28% |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 100.22% |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -35.05% |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | 85.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 85.21% |
| Sep 30, 2025 | 20.95% |
| Jun 30, 2025 | 26.08% |
| Mar 31, 2025 | 26.67% |
| Dec 31, 2024 | 18.59% |
| Sep 30, 2024 | -42.82% |
| Jun 30, 2024 | 48.90% |
| Mar 31, 2024 | 41.09% |
| Dec 31, 2023 | 31.47% |
| Sep 30, 2023 | -73.45% |
| Jun 30, 2023 | -284.18% |
| Mar 31, 2023 | -88.65% |
| Dec 31, 2022 | -43.82% |
| Sep 30, 2022 | -63.73% |
| Jun 30, 2022 | -16.01% |
| Mar 31, 2022 | 17.11% |
| Dec 31, 2021 | -188.95% |
| Sep 30, 2021 | 23.29% |
| Jun 30, 2021 | -432.33% |
| Mar 31, 2021 | -329.34% |